Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy

European Journal of Clinical Nutrition, Published online: 05 February 2025; doi:10.1038/s41430-025-01566-5

Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy

​European Journal of Clinical Nutrition, Published online: 05 February 2025; doi:10.1038/s41430-025-01566-5Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy Read More